Unlocking the power of AAV and LVV Analytics: Insights and strategies for optimizing viral vector...

Optimizing Transfection to Generate High Titer AAV and Lentiviral VectorsПодробнее

Practical strategies for overcoming challenges in the development of AAV vectors for gene therapyПодробнее

Solutions for gene therapy using a deeper analytical characterization of AAV vector developmentПодробнее

The need for next-gen AAV vectorsПодробнее

Optimizing AAV vectors with AIПодробнее

Solutions for Viral Vectors: Enabling Platform Approaches to Advance Cell and Gene TherapiesПодробнее

Biopharma 101: Analysis of Adeno-associated Viral (AAV) Vectors (SCIEX Webinar)Подробнее

How LV and AAV Transfection Platforms will Shape the Future of Gene Therapy ManufacturingПодробнее

AAV Integration Summary and ImplicationsПодробнее

Clinical challenges in developing AAV-based gene therapiesПодробнее

E. Ayuso - Unraveling mechanisms and biology of recombinant AAV vectors produced in insect cellsПодробнее

Key Considerations for Maximizing LV and AAV Production in Transient Transfection WorkflowsПодробнее

Reducing the Immunogenicity of AAV through Engineering the Vector - George ChurchПодробнее

AAV Vector Manufacturing and AnalyticsПодробнее

Webinar - A BRAVE Approach for Generating Noval AAV VectorsПодробнее

Gene Therapy Product Analytics: Where Historical and Modern Techniques MeetПодробнее

Demonstrating Analytical Comparability in Analytical DevelopmentПодробнее

Efficient and Scalable GMP Manufacture of AAV and LV with TransIT VirusGEN® Reagent and EnhancersПодробнее

Improve viral vector development outcomes with high-quality biophysical profiling dataПодробнее